MYFENAX 500 mg, film-coated tablet 50 tablets, CIP 3400930318423
Active ingredients: Mycophenolate mofetil
Commercialized according to BDPMDispensing in France: Prescription only
Tablet50 tablets, CIP 3400930318423orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MYFENAX 500 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 50 plaquettes thermoformée(s) PVC PVDC aluminium de 1 comprimé (conditionnement unitaire)
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 100 %
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 11 Sept 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Initial prescription by a hospital doctor
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61673680CIP73031842CIP133400930318423Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| MYCOPHÉNOLATE MOFÉTILcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.